Skip to content
  • Saturday, 12 September 2026
  • 6:58 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders and pioneering a new frontier in obesity therapeutics
Laboratory Automation & Robotics

OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders and pioneering a new frontier in obesity therapeutics

Lana Keisha Mar 19, 2026 0

OrsoBio, a dynamic biotech enterprise dedicated to advancing novel therapies for obesity and a spectrum of obesity-related metabolic disorders, is…

Read More
Laboratory Automation & Robotics

Novo Nordisk’s triple agonist delivers up to 19.7% average weight loss in Phase 2 trial

Lana Keisha Mar 18, 2026 0

Novo Nordisk, a global leader in diabetes and obesity care, announced a significant advancement in its weight management pipeline with…

Read More

Posts pagination

1 2 3
How most-favored-nation pricing is reshaping generic drug economics, according to Dr. Reddy’s finance directorRubedo Life Sciences Pivots from Cosmetic Enhancement to Biological Rejuvenation with Senescent Cell Clearance for Age-Related Skin ConditionsMeningitis B Vaccine Expansion Under Consideration Amidst Kent OutbreakBioengineered Human Bone Marrow-on-a-Chip Revolutionizes Drug Testing and Space Medicine Research
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease ResearchA novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative diseaseThe oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease Research
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ